Patients with high expression of CSE1L exhibited shorter survival in breast cancer (GSE4922, GSE11121), brain tumor (GSE4271), liposarcoma (GSE30929), lung cancer (GSE13213), and ovarian cancer (GSE9891). The gene discussed is CSE1L; the disease is breast carcinoma.